Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study)

Background: Epilepsy is one of the most common symptoms of brain tumors. It is often drug resistant and generally worsen patients' quality of life (QoL). Brain tumors release glutamate among other mediators, contributing to seizures onset, and this is accompanied by an increased AMPA receptors' expr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Antonietta Coppola, Alessia Zarabla, Andrea Maialetti, Veronica Villani, Tatiana Koudriavtseva, Emilio Russo, Agostino Nozzolillo, Chiara Sueri, Vincenzo Belcastro, Simona Balestrini, Edoardo Ferlazzo, Diana Giannarelli, Leonilda Bilo, Marta Maschio
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2020-06-01
coleção:	Frontiers in Neurology
Assuntos:	brain tumor-related epilepsy perampanel efficacy tolerability quality of life
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fneur.2020.00592/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!